Black Rock Inc. Legend Biotech Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,721,277 shares of LEGN stock, worth $199 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,721,277
Previous 5,384,030
6.26%
Holding current value
$199 Million
Previous $302 Million
16.09%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$260 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$236 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$208 Million7.45% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$198 Million0.86% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.5MShares$121 Million4.74% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.81B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...